Reference List
1. Chen KK, Chen AL: The alkaloids of han-fang-chi . J
Biol Chem 1935, 109: 681-685.
2. Huang Y-T, Hong C-Y: Tetrandrine . Cardiovascular Drug
Reviews 1998, 16: 1-17.
3. Schutz R, Meixner M, Antes I, Bracher F: A modular approach
to the bisbenzylisoquinoline alkaloids tetrandrine and isotetrandrine .Org.Biomol.Chem 2020.
4. Chen Y, Tsai YH, Tseng SH: The potential of tetrandrine as a
protective agent for ischemic stroke . Molecules. 2011,16: 8020-8032.
5. Bhagya N, Chandrashekar KR: Tetrandrine and cancer - An
overview of the molecular approach . Biomedicine &
Pharmacotherapy 2018, 97: 624-632.
6. Shangbin Q. Hanfanji. pp400-410. Pharmacology and application
of Chinese materia medica ,, Vol 1. Eds., Chang, H-M., and But, P. P-H,
World Scientific, 1986.
7. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J,
Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z:Characterization of spike glycoprotein of SARS-CoV-2 on virus
entry and its immune cross-reactivity with SARS-CoV . Nat.Commun.2020, 11: 1620.
8. King VF, Garcia ML, Himmel D, Reuben JP, Lam YK, Pan JX, Han GQ,
Kaczorowski GJ: Interaction of tetrandrine with slowly
inactivating calcium channels. Characterization of calcium channel
modulation by an alkaloid of Chinese medicinal herb origin . J
Biol Chem 1988, 263: 2238-2244.
9. Gunaratne GS, Yang Y, Li F, Walseth TF, Marchant JS:NAADP-dependent Ca(2+) signaling regulates Middle East
respiratory syndrome-coronavirus pseudovirus translocation through the
endolysosomal system . Cell Calcium 2018, 75: 30-41.
10. Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer
N, Grimm C, Wahl-Schott C, Biel M, Davey RA: Ebola virus.
Two-pore channels control Ebola virus host cell entry and are drug
targets for disease treatment . Science 2015,347: 995-998.
11. Dobson SJ, Mankouri J, Whitehouse A: A requirement for
potassium and calcium channels during the endolysosomal trafficing of
polyomavirus virions . bioR.xiv preprint 2019.
12. Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A,
Rosen D, Thomas JM, Izumi M, Ganesan A, Galione A, Churchill GC:Identification of a chemical probe for NAADP by virtual
screening . Nat.Chem Biol 2009, 5: 220-226.
13. Trufanov SK, Rybakova EY, Avdonin PP, Tsitrina AA, Zharkikh IL,
Goncharov NV, Jenkins RO, Avdonin PV: The Role of Two-Pore
Channels in Norepinephrine-Induced [Ca(2+)]i Rise in Rat Aortic
Smooth Muscle Cells and Aorta Contraction . Cells 2019,8 .
14. Genazzani AA, Mezna M, Dickey DM, Michelangeli F, Walseth TF,
Galione A: Pharmacological properties of the Ca2+-release
mechanism sensitive to NAADP in the sea urchin egg . Br.J
Pharmacol. 1997, 121: 1489-1495.
15. Rahman T, Cai X, Brailoiu GC, Abood ME, Brailoiu E, Patel S:Two-pore channels provide insight into the evolution of
voltage-gated Ca2+ and Na+ channels . Sci.Signal. 2014,7: ra109.
16. Chen X, Cao R, Zhong W: Host Calcium Channels and Pumps in
Viral Infections . Cells 2019, 9 .
17. Li H, Zhang LK, Li SF, Zhang SF, Wan WW, Zhang YL, Xin QL, Dai K, Hu
YY, Wang ZB, Zhu XT, Fang YJ, Cui N, Zhang PH, Yuan C, Lu QB, Bai JY,
Deng F, Xiao GF, Liu W, Peng K: Calcium channel blockers reduce
severe fever with thrombocytopenia syndrome virus (SFTSV) related
fatality . Cell Res. 2019, 29: 739-753.
18. Kim DE, Min JS, Jang MS, Lee JY, Shin YS, Song JH, Kim HR, Kim S,
Jin YH, Kwon S: Natural Bis-Benzylisoquinoline
Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human
Coronavirus OC43 Infection of MRC-5 Human Lung Cells .Biomolecules. 2019, 9: 696.
19. Falzarano D, Feldmann H: Virology. Delineating Ebola entry .Science 2015, 347: 947-948.
20. Liu C, Lv L, Guo W, Mo L, Huang Y, Li G, Huang X:Self-Nanoemulsifying Drug Delivery System of Tetrandrine for
Improved Bioavailability: Physicochemical Characterization and
Pharmacokinetic Study . Biomed.Res.Int. 2018,2018: 6763057.
21. Xie QM, Tang HF, Chen JQ, Bian RL: Pharmacological actions
of tetrandrine in inflammatory pulmonary diseases . Acta
Pharmacol.Sin. 2002, 23: 1107-1113.
22. Dai CL, Xiong HY, Tang LF, Zhang X, Liang YJ, Zeng MS, Chen LM, Wang
XH, Fu LW: Tetrandrine achieved plasma concentrations capable of
reversing MDR in vitro and had no apparent effect on doxorubicin
pharmacokinetics in mice . Cancer Chemother.Pharmacol. 2007,60: 741-750.
23. Yang G, Zhang C, Hu P, Zhu M, Hu M, Gao S: An UPLC-MS/MS
method for quantifying tetrandrine and its metabolite berbamine in human
blood: Application to a human pharmacokinetic study .J.Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2017,1070: 92-96.
24. Su W, Liang Y, Meng Z, Chen X, Lu M, Han X, Deng X, Zhang Q, Zhu H,
Fu T: Inhalation of Tetrandrine-hydroxypropyl-beta-cyclodextrin
Inclusion Complexes for Pulmonary Fibrosis Treatment . Mol.Pharm.2020.
25. Tang W, Chen J, Zhou J, Ge J, Zhang Y, Li P, Li B:Quantitative MALDI Imaging of Spatial Distributions and Dynamic
Changes of Tetrandrine in Multiple Organs of Rats . Theranostics.2019, 9: 932-944.
26. Jin H, Li L, Zhong D, Liu J, Chen X, Zheng J: Pulmonary
toxicity and metabolic activation of tetrandrine in CD-1 mice .Chem Res.Toxicol. 2011, 24: 2142-2152.
27. Sun J, Song P, Wang Y, Chen Y: Clinical efficacy of
acetylcysteine combined with tetrandrine tablets in the treatment of
silicosis and the effect on serum IL-6 and TNF-alpha .Exp.Ther.Med. 2019, 18: 3383-3388.
28. Zhang J, Wang Y, Zhang S, Li J, Fang H: Effects of
tetrandrine combined with acetylcysteine on exercise tolerance,
pulmonary function and serum TNF-beta1 and MMP-7 in silicosis patients .Exp.Ther.Med. 2020, 19: 2195-2201.
29. U.S.Department of Health and Human Services Food and Drug
Administration Center for Drug Evaluation and Research (CDER). Guidance
for Industry.Estimating the Maximum Safe Starting Dose in
Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers .
2005. https://www.fda.gov/media/72309/download